Skip to main content
Kris Kowdley, MD, Gastroenterology, Seattle, WA, Swedish First Hill Campus

KrisVKowdleyMDFACP,FACG,FASGE,AGAF

Gastroenterology Seattle, WA

Hepatology & Liver Transplantation

Director, Liver Care Network Swedish

Dr. Kowdley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kowdley's full profile

Already have an account?

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Gastroenterology, 1989 - 1991
  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Internal Medicine, 1986 - 1988
  • Oregon Health & Science University
    Oregon Health & Science UniversityInternship, Internal Medicine, 1985 - 1986
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1985

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1986 - Present
  • WA State Medical License
    WA State Medical License 1993 - 2024
  • OH State Medical License
    OH State Medical License 1991 - 1994
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
  • Elected Member The American Society for Clinical Investigation, 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diagnosis and Management of Primary Biliary Cholangitis  
    Zobair M Younossi, Kris V Kowdley, Ira M Jacobson, Mitchell L Shiffman, Paul Kwo, Nature

Other

Press Mentions

  • CymaBay Reports Third Quarter and Nine Months Ended September 30, 2022 Financial Results and Provides Corporate Update
    CymaBay Reports Third Quarter and Nine Months Ended September 30, 2022 Financial Results and Provides Corporate UpdateNovember 14th, 2022
  • Mirum Pharmaceuticals to Showcase LIVMARLI® (Maralixibat) Data at EASL and ESPGHAN Annual Congresses
    Mirum Pharmaceuticals to Showcase LIVMARLI® (Maralixibat) Data at EASL and ESPGHAN Annual CongressesJune 13th, 2022
  • HighTide Therapeutics Announces the Presentation of Topline Results of Phase 2 Study of HTD1801 in PSC Patients at the International Liver Congress 2021
    HighTide Therapeutics Announces the Presentation of Topline Results of Phase 2 Study of HTD1801 in PSC Patients at the International Liver Congress 2021June 21st, 2021
  • Join now to see all

Professional Memberships

Other Languages

  • Tamil

Hospital Affiliations